abstract |
A device is provided that allows for target treatment of neuropathy, such as diabetic peripheral neuropathy, or neuropathy and ulcers resulting from said neuropathy. The device comprises a nitric oxide (NO) eluting polymer arranged to contact a treatment area, such that a therapeutic dose of nitric oxide is eluted from said nitric oxide eluting polymer to said area. The nitric oxide (NO) eluting polymer is integrated with a carrier material, such that the carrier material, in use, regulates and controls the elution of the therapeutic dosage of nitric oxide (NO). Furthermore, a corresponding manufacturing method for the device is disclosed. |